Healthcare
CVC raises Europe’s largest ever buyout fund, securing EUR 26bn for ninth vehicle
Fund was launched in January 2023 and surpassed its EUR 25bn target, the GP said in a statement
Sluggish PE market struggles with deal execution, braces for pent-up demand wave
Financing challenges and valuation discrepancies have stymied deal count and volume, but hopes pinned on 4Q 2023 and beyond
Montefiore expects 100% re-ups for next EUR 1bn-plus fundraise
Past two fundraises saw funds oversubscribed by 3x on consistent exit track record, CEO Eric Bismuth said
Dutch VC NLC Health aims to raise a further EUR 80m for fourth fund
Plans to back companies created by NLC Venture Builder across medtech, biotech and digital tech
BioGeneration Ventures closes Fund V on EUR 150m
LP appetite for healthcare has remained strong in spite of a tough fundraising market
Stirling Square relaunches Outcomes First exit with education division sale
GP split the business into education and fostering units last year after an earlier sale attempt
IK-backed Klingel bidder ELOS Medtech frontrunner in late-stage auction
German medical equipment firm also drew sponsor interest, with some dropping out due to valuation expectations
Federated Hermes raises USD 486m for fifth co-investment fund
Fund surpassed its USD 400m target; its 2018-vintage predecessor raised USD 600m against a USD 350m target
PE purchases stall in Italy as buyers lose faith – PE Forum Italy
PE players are hoping that valuation expectations will align in 2H 2023, easing dealmaking backlog
Seven2 to launch 11th fund in next 18 months as fundraising normalcy nears
Fundraising could pick up by year-end as LP denominator effect continues to wind down
SGT Capital focuses on co-investments and LP diversification in next stretch of USD 2bn fundraise
Co-managing partner and former Mormon missionary turned financier Joseph Pacini speaks to Unquote as the firm’s current fund nears a USD 1bn-plus second close
Advent Life Sciences gears up for growth fund
Healthcare-focused strategies remain bright spot in otherwise dull fundraising market
GP Profile: NB Renaissance outlines acquisition and exit plans in final stretch of current fund deployment
Nearing full deployment for its third fund, Italian private equity firm is prepping one more deal and at least one exit by year-end
Wellington eyes late-stage growth opportunities with new USD 2.6bn fund
GP seeks to address capital needs pre-IPO or sale and anticipates a diverse portfolio for fourth fund
The Bolt-Ons Digest - 3 July 2023
Unquote’s selection of the latest add-ons with Palatine's Anthesis, Nordic Capital's Regnology, Waterland's Janssen and more
Cathay holds final close on USD 270m for PE growth fund
France-based GP’s latest private equity fund expands its geographical focus to North America
Aenova sponsor BC Partners taps Jefferies to explore exit options
GP previously attempted to sell the pharma and healthcare CDMO in 2018, Mergermarket reported
Capiton aims to launch EUR 600m fundraise for seventh fund in 2024
Next year’s fundraising timeline could avoid current tough environment
Sponsors drive record take-private activity as deployment pressure mounts
Discounted small- and mid-cap take privates expected to feed 2 pipelines amid M&A and IPO slowdown
Strada Partners heads for 2024 final close for EUR 150m debut fund
Emerging Belgian manager was formed last year and will ink deals with EUR 5m-EUR 50m equity tickets
Five Arrows launches CBA Informatique stake sale
GP invested EUR 50m in exchange for a 40% stake in the French healthcare software publisher in 2018
EQT Mid Market exits Ellab to Novo
Sale of Danish validation solutions group follows exit of BBS Automation as GP divests mid-market fund
IK-backed Klingel advances to round two with Altor among sponsors circling
Novo Holdings and AEA Investors also tipped to be in the final stretch for the German medical equipment company
TA Associates waltzes to USD 16.5bn fundraise
Seven-month raise for the US-based sponsor’s fifteenth vehicle bucks fundraising woes faced elsewhere